Osteoporosis International

, Volume 7, Issue 1, pp 36–38 | Cite as

Quality of life as outcome in the treatment of osteoporosis: The development of a questionnaire for quality of life by the European foundation for osteoporosis

  • P. Lips
  • C. Cooper
  • D. Agnusdei
  • F. Caulin
  • P. Egger
  • O. Johnell
  • J. A. Kanis
  • U. Liberman
  • H. Minne
  • J. Reeve
  • J. Y. Reginster
  • M. C. de Vernejoul
  • I. Wiklund
  • Working Party for Quality of Life of the European Foundation for Osteoporosis
Original Article

Abstract

The morbidity of osteoporosis is caused by fractures. Vertebral fractures lead to pain and disability and a decrease in quality of life. A Working Party of the European Foundation for Osteoporosis has developed a specific questionnaire for patients with established vertebral osteoporosis. This questionnaire is intended for use in clinical trials. The questionnaire consists of questions and visual analogue scales in the following domains: pain, activities of daily living, jobs around the house, mobility, leisure and social activities, general health perception and mood. The questionnaire has been translated from English into French, German, Italian, Hebrew, Swedish and Dutch. The questionnaire is currently being validated in a multicentre study involving patients with stable osteoporosis and control subjects. Preliminary results indicate that the reproducibility is sufficient and that the questionnaire is able to discriminate between patients with vertebral osteoporosis and control subjects.

Keywords

Quality of life Osteoporosis Vertebral fractures 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kanis JA, Geusens P, Christiansen C, on behalf of the Working Party of the Foundation. Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporosis Int 1991;1:182–8.Google Scholar
  2. 2.
    Reginster JY, Compston JE, on behalf of the Group for the Respect of Ethics and Excellence in Science. Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis. Calcif Tissue Int 1995;57:247–50.Google Scholar
  3. 3.
    Leidig G, Minne HW, Sauer P, et al. A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner 1990;8:217–29.Google Scholar
  4. 4.
    Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I. Applications and issues in assessment. BMJ 1992;305:1074–7.Google Scholar
  5. 5.
    Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II. Design, analysis and interpretation. BMJ 1992;305:1145–8.Google Scholar
  6. 6.
    Kanis JA, Minne HW, Meunier PJ, Ziegler R, Allender E. Quality of life and vertebral osteoporosis. Osteoporosis Int 1992;2:161–3.Google Scholar
  7. 7.
    Hunt S, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985;35:185–8.Google Scholar
  8. 8.
    Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787–805.Google Scholar
  9. 9.
    Brazier JE, Harper R, Jones NMB, et al. Validating the SF36 health survey questionnaire: new outcome measures for primary care. BMJ 1992;305:160–4.Google Scholar
  10. 10.
    Dequeker J, Ramstam J, Valsson J, et al. The Mediterranean Osteoporosis (MEDOS) study questionnaire. Clin Rheumatol 1991;10:54–72.Google Scholar
  11. 11.
    European Vertebral Osteoporosis Study (EVOS). Questionnaire. Harrow, UK, 1990.Google Scholar

Copyright information

© European Foundation for Osteoporosis and the National Osteoporosis Foundation 1997

Authors and Affiliations

  • P. Lips
    • 1
  • C. Cooper
  • D. Agnusdei
  • F. Caulin
  • P. Egger
  • O. Johnell
  • J. A. Kanis
  • U. Liberman
  • H. Minne
  • J. Reeve
  • J. Y. Reginster
  • M. C. de Vernejoul
  • I. Wiklund
  • Working Party for Quality of Life of the European Foundation for Osteoporosis
  1. 1.Department of EndocrinologyAcademisch Ziekenhuis Vrije UniversiteitAmsterdamThe Netherlands

Personalised recommendations